EP Biocomposites
EP Biocomposites (EPBIO) share price was ₹90.00 at the 27 Oct 2026 close; market capitalisation ₹15.17 Cr; sector Utilities. The share price fell 26.8% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹9.57 Cr, against ₹7.60 Cr a year earlier and net profit was ₹1.37 Cr, against ₹0.83 Cr a year earlier (compared with Mar 2025). Promoters held 70.08% of EP Biocomposites in Sep 2026, unchanged from Jun 2026.
Key Fundamentals
SMEOther UtilitiesUtilitiesPrice-based figures as of 29 Oct 2026, 09:32 IST · TTM
Peer Comparison
Utilities › Waste Management
| ₹223.10 | 12.33 | 3,062 Cr | 1.91 | 0.65% | 16.07% | 22.69% | 2,869 Cr | 248 Cr | |
| ₹290.95 | 23.69 | 1,616 Cr | 1.53 | 0.51% | 8.62% | 12.15% | 664 Cr | 68 Cr | |
| ₹287.40 | 13.96 | 816 Cr | 1.10 | 0.17% | 10.02% | 11.52% | 1,099 Cr | 70 Cr | |
| ₹349.75 | 134.52 | 800 Cr | 7.75 | 0.00% | 13.91% | 19.89% | 66 Cr | 4 Cr | |
| ₹336.70 | — | 779 Cr | 6.31 | 0.30% | 23.17% | 30.51% | — | — | |
| ₹401.25 | 15.72 | 597 Cr | 2.83 | 0.00% | 11.47% | 15.95% | 95 Cr | 37 Cr | |
| ₹84.10 | — | 14 Cr | 1.17 | 0.00% | 12.10% | 16.24% | — | — | |
| Median 7 companies | ₹290.95 | 15.72 | 800 Cr | 1.91 | 0.17% | 12.10% | 16.24% | 664 Cr | 68 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.0% over last 3 years.
- Company has high debtors of 317 days.
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 20.79% · Mar 2026
Quarterly Results
| Particulars | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.76 | 5.3 | 3.45 | 3.68 | 4.4 | 7.04 | 4.4 | 7.6 | 4.07 | 9.57 |
| Expenses | 2.42 | 4.27 | 2.92 | 3.26 | 4.14 | 5.9 | 3.91 | 6.31 | 3.82 | 7.58 |
| Operating Profit | 0.34 | 1.03 | 0.53 | 0.42 | 0.26 | 1.14 | 0.49 | 1.29 | 0.25 | 1.99 |
| OPM % | 12.32% | 19.43% | 15.36% | 11.41% | 5.91% | 16.19% | 11.14% | 16.97% | 6.14% | 20.79% |
| Other Income | 0 | 0.01 | 0.03 | 0.13 | 0.09 | 0.21 | 0.05 | 0.06 | 0.07 | 0.07 |
| Interest | 0.02 | 0.13 | 0.15 | 0.05 | 0.01 | 0.02 | 0.17 | 0.19 | 0.15 | 0.19 |
| Depreciation | 0.01 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| PBT | 0.31 | 0.85 | 0.36 | 0.45 | 0.29 | 1.28 | 0.32 | 1.1 | 0.12 | 1.82 |
| Tax % | 25.81% | 32.94% | 25% | 33.33% | 27.59% | 27.34% | 34.38% | 25.45% | 33.33% | 24.73% |
| Net Profit | 0.24 | 0.57 | 0.27 | 0.3 | 0.22 | 0.93 | 0.21 | 0.83 | 0.09 | 1.37 |
| EPS (₹) | 2.04 | 4.84 | 1.61 | 1.78 | 1.31 | 5.53 | 1.25 | 4.94 | 0.54 | 8.15 |
Profit & Loss
| Particulars | Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | 13.64 |
| Expenses | 0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | 11.4 |
| Operating Profit | 0.04 | 0.46 | 1.4 | 0.97 | 1.41 | 1.78 | 2.24 |
| OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.82% | 16.42% |
| Other Income | 0 | 0 | 0.02 | 0.17 | 0.3 | 0.11 | 0.14 |
| Interest | 0 | 0 | 0.19 | 0.23 | 0.04 | 0.36 | 0.34 |
| Depreciation | 0 | 0 | 0.07 | 0.1 | 0.1 | 0.11 | 0.1 |
| PBT | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.94 |
| Tax % | 25% | 23.91% | 31.03% | 28.4% | 26.75% | 27.46% | 24.74% |
| Net Profit | 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 |
| EPS (₹) | 0.75 | 9 | 6.88 | 3.45 | 6.84 | 6.13 | 8.68 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 10.37 |
| Borrowings | 0 | 0 | 4.11 | 1.28 | 1.8 | 2.98 | 2.39 |
| Other Liabilities | 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 4.3 |
| Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.74 |
| Fixed Assets | 0 | 0 | 0.41 | 0.33 | 0.33 | 0.23 | 0.24 |
| CWIP | 0 | 0 | 0 | 0 | 0.14 | 0.14 | 0.62 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 17.88 |
| Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.74 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | 1.99 |
| Investing | 0 | 0 | -0.47 | 0.02 | -0.16 | 0.02 | -0.53 |
| Financing | 0 | 0 | 4.76 | 2.81 | 0.49 | 0.82 | -0.92 |
| Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 | 0.54 |
| Free Cash Flow | 0.12 | 0.03 | -4.75 | -0.81 | -1.48 | -0.5 | 1.41 |
| CFO/EBITDA | 300 | 9 | -294 | -44 | -59 | -1 | 105 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 192 | 80.42 | 322 | 300 | 287 | 330 | 317 |
| Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 | 56.54 |
| Days Payable | 350 | 128 | 162 | 105 | 143 | 97.87 | 114 |
| Cash Conversion Cycle | -74.04 | 42.32 | 246 | 286 | 194 | 299 | 260 |
| Working Capital Days | -57.63 | 25.98 | 157 | 256 | 217 | 271 | 237 |
| ROCE % | — | 219.05% | 41.54% | 13.16% | 15.3% | 14.28% | 16.28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view EP Biocomposites insights
60 extracted metrics + investor summaries across FY13–FY26.
Documents
Frequently Asked Questions about EP Biocomposites
What does EP Biocomposites Ltd do?
Where is EP Biocomposites Ltd (EPBIO) listed?
Which sector does EP Biocomposites Ltd belong to?
What is the market capitalisation of EP Biocomposites Ltd?
What is the 52-week high and low of EP Biocomposites Ltd?
What is the Return on Equity (ROE) of EP Biocomposites Ltd?
Company Information
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543595.md for EP Biocomposites Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.